"At East Florida Eye Institute, we pride ourselves on offering patients the latest and most advanced treatments and techniques for ocular disease, customized to each individual’s needs! Major pharmaceutical companies recognize us as a clinical study center for national, randomized, FDA-Sponsored drug trials. Over the last few years we’ve participated in nearly a dozen clinical trials, and we’re currently enrolling patients in upcoming clinical trials. We strive to move forward in every aspect of the practice as we are constantly evolving new treatments, new treatment plans, the most up-to-date disease monitoring systems and patient-doctor relationships through personalized and individualized care."

During the past decade, East Florida Eye Institute conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 7 clinical trials were completed, i.e. on average, 58.3% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 5 clinical trials were completed. i.e. 125% of trials that started reached the finish line.

Out of the total clinical trials conducted in "East Florida Eye Institute" #1 sponsor was "Allergan" with 2 trials, followed by "Apellis Pharmaceuticals, Inc." with 2 trials sponsored, "Santen Inc." with 2 trials sponsored, "Shire" with 2 trials sponsored and "Aerie Pharmaceuticals" with 2 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "East Florida Eye Institute" #1 collaborator was "Genentech, Inc." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "East Florida Eye Institute" are "Geographic Atrophy" (3 trials), "Macular Degeneration" (3 trials), "Ocular Hypertension" (2 trials), ""Wet" Age-Related Macular Degeneration" (1 trials) and "Adenoviral Conjunctivitis" (1 trials). Many other conditions were trialed in "East Florida Eye Institute" in a lesser frequency.

Most popular intervention types in "East Florida Eye Institute" are "Drug" (17 trials) and "Other" (6 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "PVP-I 0.6%" (2 trials), "Ranibizumab" (2 trials), "SHP640" (2 trials) and "Sham Procedure" (2 trials). Other intervention names were less common.

The vast majority of trials in "East Florida Eye Institute" are 17 trials for "All" genders.

Currently, there are NaN active trials in "East Florida Eye Institute". undefined are not yet recruiting, undefined are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in East Florida Eye Institute, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in East Florida Eye Institute, 0 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".